Latest Ikaria Stories
HAMPTON, N.J., Jan.
CLINTON, N.J., July 28 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today that the U.S.
Ikaria, through its subsidiary Ino Therapeutics, has announced that the Japan's Ministry of Health, Labor, and Welfare's Council on Drugs and Food Sanitation has recommended approval of the company's INOflo for inhalation.
- A handkerchief.
- In general, any miraculous portrait of Christ.